[1]
Lunn M.R., Wang C.H., Spinal muscular atrophy. Lancet, 2008, 371, 2120-2133 PubMedCrossrefGoogle Scholar
[2]
Ahmad S., Bhatia K., Kannan A., Gangwani L., Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy, J. Exp. Neuroscience., 2016, 10, 39-49 Google Scholar
[3]
Lefebvre S., Bürglen L., Reboullet S., Clermont O., Burlet P., Viollet L., et al., Identification and characterization of a spinal muscular atrophydetermining gene, Cell, 1995, 80, 155-165 CrossrefPubMedGoogle Scholar
[4]
Wirth B., An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA), Hum. Mut., 2000, 15, 228-237 CrossrefGoogle Scholar
[5]
Singh R.N., Howell M.D., Ottesen E.W., Singh N.N., Diverse role of Survival Motor Neuron protein, BBA Gene Reg. Mech., (in press) CrossrefGoogle Scholar
[6]
Lorson C.L., Hahnen E., Androphy E.J., Wirth B., A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy, Proc. Natl. Acad. Sci. U. S. A. 1999, 96, 6307-6311 CrossrefPubMedGoogle Scholar
[7]
Monani U.R., Lorson C.L., Parsons D.W., Prior T.W., Androphy E.J., Burghes A.H.M., et al., A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2, Hum. Mol. Genet.. 1999, 8, 1177-1183 PubMedCrossrefGoogle Scholar
[8]
Cho S.C., Dreyfuss G., A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity, Genes Dev., 2010, 24, 438-442 PubMedCrossrefGoogle Scholar
[9]
Singh N.N., Seo J., Rahn S.J., Singh R.N., A Multi-Exon-Skipping Detection Assay Reveals Surprising Diversity of Splice Isoforms of Spinal Muscular Atrophy Genes, Plos One, 2012, 7, 17 Google Scholar
[10]
Seo J., Singh N.N., Ottesen E.W., Sivanesan S., Shishimorova M., Singh R.N., Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene, Plos One, 2016, 11, 31 Google Scholar
[11]
Seo J., Singh N.N., Ottesen E.W., Lee B.M., Singh R.N., A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein, Sci. Rep., 2016, 6, 14Google Scholar
[12]
Setola V., Terao M., Locatelli D., Bassanini S., Garattini E., Battaglia G.. Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, 1959-1964 CrossrefPubMedGoogle Scholar
[13]
Ottesen E.W., Howell M.D., Singh N.N., Seo J., Whitley E.M., Singh R.N., Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy, Sci. Rep., 2016, 6, 17 Google Scholar
[14]
Cartegni L., Krainer A.R., Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1, Nat. Genet., 2002, 30, 377-384 PubMedCrossrefGoogle Scholar
[15]
Kashima T., Manley J.L., A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy, Nat. Genet., 2003, 34, 460-463CrossrefPubMedGoogle Scholar
[16]
Singh N.N., Androphy E.J., Singh R.N., An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy, Biochem. Biophys. Res. Commun., 2004, 315, 381-388CrossrefPubMedGoogle Scholar
[17]
Singh N.N., Androphy E.J., Singh R.N., In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes, RNA, 2004, 10, 1291-1305 PubMedCrossrefGoogle Scholar
[18]
Singh N.N., Androphy E.J., Singh R.N., The regulation and regulatory activities of alternative splicing of the SMN gene, Crit. Rev. Eukaryot. Gene Expr., 2004, 14, 271-285PubMedCrossrefGoogle Scholar
[19]
Singh R.N., Unfolding the mystery of alternative splicing through a unique method of in vivo selection, Front. Biosci., 2007, 12, 3263-3272 Google Scholar
[20]
Singh N.N., Singh R.N., Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model, RNA Biol., 2011, 8, 600-606 PubMedCrossrefGoogle Scholar
[21]
Singh N.N., Howell M.D., Singh R.N., Transcriptional and Splicing Regulation of Spinal Muscular Atrophy Genes. In: Spinal Muscular Atrophy: Disease Mechanisms and Therapy (ed. Charlotte S.J., Paushkin S., Ko C.-P.), Elsevier Inc., 2016 Google Scholar
[22]
Seo J., Howell M.D., Singh N.N., Singh R.N., Spinal muscular atrophy: An update on therapeutic progress, Biochim. Biophys. Acta-Mol. Basis Dis., 2013, 1832, 2180-2190 CrossrefGoogle Scholar
[23]
Awano T., Kim J.K., Monani U., Spinal Muscular Atrophy: Journeying From Bench to Bedside, NeuroRx., 2014, 11, 786-795 Google Scholar
[24]
Howell M.D., Singh N.N., Singh R.N., Advances in therapeutic development for spinal muscular atrophy, Future Med. Chem., 2014, 6, 1081-1099 PubMedCrossrefGoogle Scholar
[25]
Mohseni J., Zabidi-Hussin Z., Sasongko T.H., Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy, Genet. Mol. Biol., 2013, 36, 299-307 CrossrefPubMedGoogle Scholar
[26]
Branchu J., Biondi O., Chali F., Collin T., Leroy F., Mamchaoui K., et al., Shift from Extracellular Signal-Regulated Kinase to AKT/cAMP Response Element-Binding Protein Pathway Increases Survival-Motor-Neuron Expression in Spinal-Muscular-Atrophy-Like Mice and Patient Cells, J. Neurosci. 2013, 33, 4280-+ CrossrefPubMedGoogle Scholar
[27]
Baughan T.D., Dickson A., Osman E.Y., Lorson C.L., Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy, Hum. Mol. Genet., 2009, 18, 1600-1611 CrossrefGoogle Scholar
[28]
Hua Y., Sahashi K., Rigo F., Hung G., Horev G., Bennett C.F., et al., Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model, Nature, 2011, 478, 123-126 CrossrefPubMedGoogle Scholar
[29]
Sivanesan S., Howell M.D., DiDonato C.J., Singh R.N., Antisense oligonucleotide mediated therapy of spinal muscular atrophy. Transl. Neurosci., 2013, 4, 1-7CrossrefGoogle Scholar
[30]
Singh N.N., Lee B.M., DiDonato C.J., Singh R.N., Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy, Fut. Med. Chem., 2015, 7, 1793-1808 CrossrefGoogle Scholar
[31]
Heier C.R., DiDonato C.J., Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo, Hum. Mol. Genet., 2009, 18, 1310-1322 PubMedCrossrefGoogle Scholar
[32]
Hsu S.H., Lai M.C., Er T.K., Yang S.N., Hung C.H., Tsai H.H., et al., Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts, Clin. Chim. Acta, 2010, 411, 1920-1928 CrossrefPubMedGoogle Scholar
[33]
Han K.J., Foster D.G., Zhang N.Y., Kanisha K., Dzieciatkowska M., Sclafani R.A., et al., Ubiquitin-specific Protease 9x Deubiquitinates and Stabilizes the Spinal Muscular Atrophy Protein-Survival Motor Neuron, J. Biol. Chem., 2012, 287, 43741-43752 PubMedCrossrefGoogle Scholar
[34]
Seo J., Ottesen E.W., Singh R.N., Antisense Methods to Modulate Pre-mRNA Splicing, Meth. Mol. Biol., 2014, 1126, 271-283 CrossrefGoogle Scholar
[35]
Hua Y., Vickers T.A., Okunola H.L., Bennett C.F., Krainer A.R., Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in transgenic mice, Am. J. Hum. Genet. 2008, 82, 834-848 CrossrefPubMedGoogle Scholar
[36]
Singh N.N., Seo J.B., Ottesen E.W., Shishimorova M., Bhattacharya D., Singh R.N., TIA1 Prevents Skipping of a Critical Exon Associated with Spinal Muscular Atrophy, Mol. Cell. Biol., 2011, 31, 935-954 PubMedCrossrefGoogle Scholar
[37]
Singh N.N., Hollinger K., Bhattacharya D., Singh R.N., An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre-mRNA splicing, RNA, 2010, 16, 1167-1181 PubMedCrossrefGoogle Scholar
[38]
Singh N.N., Lawler M.N., Ottesen E.W., Upreti D., Kaczynski J.R., Singh R.N., An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy, Nucl. Acids Res., 2013, 41, 8144-8165 CrossrefGoogle Scholar
[39]
Singh N.N., Lee B.M., Singh R.N., Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions, DNA Habitats and Their RNA Inhabitants, 2015, 1341, 176-187 Google Scholar
[40]
Cartegni L., Krainer A.R., Correction of disease-associated exon skipping by synthetic exon-specific activators, Nat. Struct. Biol., 2003, 10, 120-125 PubMedCrossrefGoogle Scholar
[41]
Meyer K., Marquis J., Trub J., Nlend R.N., Verp S., Ruepp M.D., et al., Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation, Hum. Mol. Genet., 2009, 18, 546-555 PubMedCrossrefGoogle Scholar
[42]
Owen N., Zhou H.Y., Malygin A.A., Sangha J., Smith L.D., Muntoni F., et al., Design principles for bifunctional targeted oligonucleotide enhancers of splicing, Nucl. Acids Res., 2011, 39, 7194-7208 CrossrefGoogle Scholar
[43]
Singh R.N., Singh N.N., Singh N.K., Androphy E.J.,. Spinal muscular atrophy (SMA) treatment via targeting of SMN2 splice site inhibitory sequences, US patent publication # US7838657, 2010 (Also published as US8110560, US8586559, US9476042, US20070292408, US20100087511, US20120165394, US20140066492) Google Scholar
[44]
Singh N.K., Singh N.N., Androphy E.J., Singh R.N., Splicing of a critical exon of human survival motor neuron is regulated by a unique silencer element located in the last intron, Mol. Cell. Biol., 2006, 26, 1333-1346 PubMedCrossrefGoogle Scholar
[45]
Buratti E., Baralle M., Baralle F.E., Defective splicing, disease and therapy: searching for master checkpoints in exon definition, Nucl. Acids Res., 2006, 34, 3494-3510 CrossrefGoogle Scholar
[46]
Singh N.N., Seo J., Singh R.N., Identification of Splicing cis-Elements Through an Ultra-Refined Antisense Microwalk, in Alternative premRNA Splicing: Theory and Protocols (eds S. Stamm, C. W. J. Smith and R. Lührmann), Wiley-VCH Verlag GmbH & Co., KGaA, Weinheim, Germany, 2012 Google Scholar
[47]
Singh R.N., Singh, N.N., Functional Analysis of Large Exonic Sequences Through Iterative In Vivo Selection, in Alternative pre-mRNA Splicing: Theory and Protocols (eds S. Stamm, C. W. J. Smith and R. Lührmann), Wiley-VCH Verlag GmbH & Co., KGaA, Weinheim, Germany, 2012 Google Scholar
[48]
Singh N.N., Singh R.N., Androphy E.J., Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes, Nucl. Acids Res., 2007, 35, 371-389 Google Scholar
[49]
Williams J.H., Schray R.C., Patterson C.A., Ayitey S.O., Tallent M.K., Lutz G.J., Oligonucleotide-Mediated Survival of Motor Neuron Protein Expression in CNS Improves Phenotype in a Mouse Model of Spinal Muscular Atrophy, J. Neurosci., 2009, 29, 7633-7638 CrossrefGoogle Scholar
[50]
Hua Y.M., Sahashi K., Hung G.N., Rigo F., Passini M.A., Bennett C.F., et al., Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model, Genes Dev., 2010, 24, 1634-1644CrossrefGoogle Scholar
[51]
Passini M.A., Bu J., Richards A.M., Kinnecom C., Sardi S.P., Stanek L.M., et al., Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy, Sci. Transl. Med., 2011, 3, 11Google Scholar
[52]
Osman E.Y., Yen P.F., Lorson C.L., Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy, Mol. Ther., 2012, 20, 119-126CrossrefGoogle Scholar
[53]
Porensky P.N., Mitrpant C., McGovern V.L., Bevan A.K., Foust K.D., Kaspar B.K., et al., A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse, Hum. Mol. Genet., 2012, 21, 1625-1638 CrossrefPubMedGoogle Scholar
[54]
Zhou H., Janghra N., Mitrpant C., Dickinson R.L., Anthony K., Price L., et al., A novel morpholino oligomer targeting ISS-N1 improves rescue of severe spinal muscular atrophy transgenic mice, Hum. Gene. Ther., 2013, 24, 331-342CrossrefPubMedGoogle Scholar
[55]
Mitrpant C., Porensky P., Zhou H.Y., Price L., Muntoni F., Fletcher S., et al., Improved Antisense Oligonucleotide Design to Suppress Aberrant SMN2 Gene Transcript Processing: Towards a Treatment for Spinal Muscular Atrophy, Plos One, 2013, 8, 10Google Scholar
[56]
Zhou H.Y., Meng J.H., Marrosu E., Janghra N., Morgan J., Muntoni F., Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response, Hum. Mol. Genet., 2015, 24, 6265-6277PubMedCrossrefGoogle Scholar
[57]
Sintusek P., Catapano F., Angkathunkayul N., Marrosu E., Parson S.H., Morgan J.E., et al., Histopathological Defects in Intestine in Severe Spinal Muscular Atrophy Mice Are Improved by Systemic Antisense Oligonucleotide Treatment, Plos One, 2016, 11, 15 Google Scholar
[58]
Szunyogova E., Zhou H.Y., Maxwell G.K., Powis R.A., Francesco M., Gillingwater T.H., et al., Survival Motor Neuron (SMN) protein is required for normal mouse liver development, Sci. Rep., 2016, 6, 14 Google Scholar
[59]
Hammond S.M., Hazell G., Shabanpoor F., Saleh A.F., Bowerman M., Sleigh J.N., et al., Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy, Proc. Natl. Acad. Sci. U. S. A., 2016, 113, 10962-10967 CrossrefPubMedGoogle Scholar
[60]
Chiriboga C.A., Swoboda K.J., Darras B.T., Iannaccone S.T., Montes J., De Vivo D.C., et al., Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy, Neurol., 2016, 86, 890-897 CrossrefGoogle Scholar
[61]
Finkel R.S., Chiriboga C.A., Vajsar J., Day J.W., Montes J., De Vivo D.C., et al., Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study, Lancet, 2017, 388, 3017-3026. Epub 2016/12/07 Google Scholar
[62]
Zhang Z.X., Pinto A.M., Wan L.L., Wang W., Berg M.G., Oliva I., et al., Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy, Proc. Natl. Acad. Sci. U. S. A., 2013, 110, 19348-19353 PubMedCrossrefGoogle Scholar
[63]
Heier C.R., Satta R., Lutz C., DiDonato C.J., Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice, Hum. Mol. Genet., 2010, 19, 3906-3918 CrossrefPubMedGoogle Scholar
[64]
Shababi M., Habibi J., Yang H.T., Vale S.M., Sewell W.A., Lorson C.L., Cardiac defects contribute to the pathology of spinal muscular atrophy models, Hum. Mol. Genet., 2010, 19, 4059-4071PubMedCrossrefGoogle Scholar
[65]
Gombash S.E., Cowley C.J., Fitzgerald J.A., Iyer C.C., Fried D., McGovern V.L., et al., SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice, Hum. Mol. Genet., 2015, 24, 3847-3860CrossrefPubMedGoogle Scholar
[66]
Thomson A.K., Somers E., Powis R.A., Shorrock H.K., Murphy K., Swoboda K.J., et al., Survival of motor neurone protein is required for normal postnatal development of the spleen, J. Anat., 2016., Epub 2016/10/11 PubMedGoogle Scholar
[67]
Miyajima H., Miyaso H., Okumura M., Kurisu J., Imaizumi K., Identification of a cis-acting element for the regulation of SMN exon 7 splicing, J. Biol. Chem., 2002, 277, 23271-23277 CrossrefPubMedGoogle Scholar
[68]
Singh N.N., Shishimorova M., Cao L.C., Gangwani L., Singh R.N., A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy, RNA Biol., 2009, 6, 341-350 CrossrefGoogle Scholar
[69]
Keil J.M., Seo J., Howell M.D., Hsu W.H., Singh R.N., DiDonato CJ., A Short Antisense Oligonucleotide Ameliorates Symptoms of Severe Mouse Models of Spinal Muscular Atrophy, Mol. Ther.-Nucleic Acids. 2014, 3, 10 Google Scholar
[70]
d’Ydewalle C., Ramos D.M., Pyles N.J., Ng S.Y., Gorz M., Pilato C.M., et al., The Antisense Transcript SMN-AS1 Regulates SMN Expression and Is a Novel Therapeutic Target for Spinal Muscular Atrophy, Neuron, 2016, Epub 2016/12/21 PubMedGoogle Scholar
[71]
Pao P.W., Wee K.B., Yee W.C., DwiPramono Z.A.., Dual Masking of Specific Negative Splicing Regulatory Elements Resulted in Maximal Exon 7 Inclusion of SMN2 Gene, Mol. Ther., 2014, 22, 854-861 PubMedCrossrefGoogle Scholar
Comments (0)